Equity Research Health Information Services

Should You Buy Teladoc Health, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 7/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Teladoc Health, Inc. (TDOC) occupies a solid middle-ground position with a Quality of Company score of 7.3/10. At the current market price of $6.58, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 7 of 7 CirclFi valuation models project upside for Teladoc Health, Inc. (TDOC) at $6.58 — the model consensus leans bullish, with a Quality Score of 7.3/10 and Value-Trap risk of 26/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 7 of 7 models see upside — majority bullish
  • Quality Score: 7.3/10 — Strong — above-average quality
  • Value Trap Risk: 26/100 — Low — manageable risk
  • Fair Value Range: $10.48 – $23.59 (125% spread)

Bullish Models

7 / 7

Bearish Models

0 / 7

Quality Score

7.3 /10

Strong — above-average quality

Value Trap Risk

26 /100
Low

Low — manageable risk

Model Consensus

7 /13
Active Models

Avg. confidence: 41%

What Is the Investment Case for Teladoc Health, Inc. (TDOC) in 2026?

What Is the Bull Case vs the Bear Case for Teladoc Health, Inc. (TDOC)?

Bull case versus bear case for Teladoc Health, Inc. (TDOC) at $6.58, derived from 7 active CirclFi valuation models on 2026-09-15.
Bull case — $23.59 target (+258.6%) Bear case
According to the CirclFi Quality of Company (QOC) framework, Teladoc Health, Inc.'s score of 7.3/10 reflects durable competitive advantages that should sustain earnings power through market cycles. No active model flags significant downside for TDOC. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +97.1% across 7 bullish models from the current price of $6.58.
According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model targets a fair value of $23.59 (+258.6%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does TDOC Compare to Its Health Information Services Peers?

SLP Simulations Plus, In
7.4
BTSG BrightSpring Health
7.2
LFMD LifeMD, Inc.
7.5
SDGR Schrödinger, Inc.
7.1
OMCL Omnicell, Inc.
7.5
NRC NRC Health
7.0
HTFL Heartflow, Inc.
6.1
VSEE VSee Health, Inc.
4.8

Valuation data pages: SLP · BTSG · LFMD · SDGR · OMCL · NRC · HTFL · VSEE · VEEV · DOCS · HQY

See full Health Information Services rankings →

Which Other Stocks Score Like TDOC on Quality?

Closest companies to TDOC’s Quality of Company score of 7.3/10, across all industries.

Why Do CirclFi’s 7 Models Disagree on TDOC?

Spread

125%

Fair Value Range

$10.48 – $23.59

A 125% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

FTNN

$23.59 (+258.6%)

Most Bearish

Sentiment SOTP

$10.48 (+59.3%)

What Are the Biggest Risks of Buying TDOC Stock?

Model Disagreement

125% spread signals high variance in projections.

Macro/Sector Risk

Health Information Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View TDOC Data Page →

So Is Teladoc Health, Inc. (TDOC) Worth Buying in 2026?

The convergence of 7.3/10 quality, multi-model undervaluation (7/7 bullish, +97.1% median upside), and a median fair value of $12.97 vs. $6.58 current price makes Teladoc Health, Inc. one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.

These are quantitative model outputs, not investment recommendations. Teladoc Health, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About TDOC Stock?

Should I buy TDOC stock right now?

Based on CirclFi's multi-model analysis, 7 of 7 models see upside for TDOC at $6.58. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Teladoc Health, Inc.?

Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (125% spread), signaling high uncertainty; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.

How does TDOC compare to its competitors?

Among Health Information Services peers, TDOC holds a Quality Score of 7.3/10. Comparable companies include SLP (QOC 7.4), BTSG (QOC 7.2), LFMD (QOC 7.5). The relative ranking helps investors identify whether TDOC offers better fundamental quality than alternatives in the same sector.

Is TDOC a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. TDOC's Quality Score of 7.3/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy TDOC at?

CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $10.48 to $23.59. At $6.58, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for TDOC.

View TDOC Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →